KANG [iKang Healthcare] 8-A12B/A: FORM 8-A/A Amendment No. 2 FOR REGISTRATION OF

[FORM 8-A/A Amendment No. 2 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES iKang Healthcare Group, Inc. Cayman Islands Not Applicable (State of incorporation or organization) (IRS Employer B-6F, Shimao Tower 92A Jianguo Road People’s Republic of China x o (if applicable) Title of each class Name o]

KANG [iKang Healthcare] 6-K: (Original Filing)

[AMENDMENT NO. 2 TO RIGHTS AGREEMENT EXECUTION VERSION WHEREAS, the Board of Directors of the Company desires to amend the Rights Agreement to extend the Expiration Time; WHEREAS, the Flip-In Date has not occurred; WHEREAS, the Special Committee has approved this Amendment; and NOW THEREFORE, in cons]

KANG [iKang Healthcare] 6-K: AMENDMENT NO. 2 TO RIGHTS AGREEMENT EXECUTION VERSION

[AMENDMENT NO. 2 TO RIGHTS AGREEMENT EXECUTION VERSION WHEREAS, the Board of Directors of the Company desires to amend the Rights Agreement to extend the Expiration Time; WHEREAS, the Flip-In Date has not occurred; WHEREAS, the Special Committee has approved this Amendment; and NOW THEREFORE, in cons]

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Unaudited Financial Results for the Fiscal First Quarter Ended June 30, 2017 BEIJING, September 14, 2017 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, ]

KANG [iKang Healthcare] 6-K: iKang Announces Unaudited Financial Results for the Fiscal

[iKang Announces Unaudited Financial Results for the Fiscal First Quarter Ended June 30, 2017 BEIJING, September 14, 2017 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, ]

KANG [iKang Healthcare] SC 13D/A: (Original Filing)

[Execution Version Dated 25 August 2017 Charge over Shares Relating to the share capital of iKang Healthcare Group, Inc. in relation to a US$19,000,000 Term Loan Facility between ShanghaiMed, Inc. as Chargor Gopher Global Credit Fund II as Chargee White & Case 9th Floor Central Tower 28 Queen’s Road ]

KANG [iKang Healthcare] SC 13D/A: Execution Version Dated 25 August 2017 Charge over

[Execution Version Dated 25 August 2017 Charge over Shares Relating to the share capital of iKang Healthcare Group, Inc. in relation to a US$19,000,000 Term Loan Facility between ShanghaiMed, Inc. as Chargor Gopher Global Credit Fund II as Chargee White & Case 9th Floor Central Tower 28 Queen’s Road ]

KANG [iKang Healthcare] 20-F: * Not for trading, but only in connection

[* Not for trading, but only in connection with the listing on The NASDAQ Global Select Market of American depositary shares. Currently, two ADSs represent one Class A common shares. None (Title of Class) None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes ]

Skip to toolbar